These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 2723957)

  • 21. Polybutylcyanoacrylate magnetic nanoparticles as carriers of adriamycin.
    Cai L; Niu G; Hu Z; Jin W; Wang J; Sun L
    J Drug Target; 2009 Apr; 17(3):200-6. PubMed ID: 19558359
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vitro--in vivo evaluation of tableted caseinchitosan microspheres containing diltiazem hydrochloride.
    al-Suwayeh SA; el-Helw AR; al-Mesned AF; Bayomi MA; el-Gorashi AS
    Boll Chim Farm; 2003; 142(1):14-20. PubMed ID: 12680034
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Study of the preparation of sustained-release microspheres containing zedoary turmeric oil by the emulsion-solvent-diffusion method and evaluation of the self-emulsification and bioavailability of the oil.
    You J; Cui FD; Han X; Wang YS; Yang L; Yu YW; Li QP
    Colloids Surf B Biointerfaces; 2006 Mar; 48(1):35-41. PubMed ID: 16480856
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Egg albumin microspheres containing sulphamethizole.
    Brophy MR; Deasy PB
    J Microencapsul; 1984; 1(2):157-68. PubMed ID: 6336524
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Application of epirubicin containing albumin microspheres in the experimental therapy of breast cancer.
    Novotný J; Zinek K
    Neoplasma; 1994; 41(4):201-4. PubMed ID: 7935992
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Optimization of doxorubicine incorporation and of the yield of polybutylcyanacrylate nanoparticles.
    Carpignano R; Gasco MR; Morel S
    Pharm Acta Helv; 1991; 66(1):28-32. PubMed ID: 1758887
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bupivacaine-loaded biodegradable poly(lactic-co-glycolic) acid microspheres I. Optimization of the drug incorporation into the polymer matrix and modelling of drug release.
    Zhang H; Lu Y; Zhang G; Gao S; Sun D; Zhong Y
    Int J Pharm; 2008 Mar; 351(1-2):244-9. PubMed ID: 18024022
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A novel pH-dependent gradient-release delivery system for nitrendipine: I. Manufacturing, evaluation in vitro and bioavailability in healthy dogs.
    Yang M; Cui F; You B; You J; Wang L; Zhang L; Kawashima Y
    J Control Release; 2004 Aug; 98(2):219-29. PubMed ID: 15262414
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Thermal behavior and stability of biodegradable spray-dried microparticles containing triamcinolone.
    da Silva AA; de Matos JR; Formariz TP; Rossanezi G; Scarpa MV; do Egito ES; de Oliveira AG
    Int J Pharm; 2009 Feb; 368(1-2):45-55. PubMed ID: 18992313
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chitosan microspheres of diclofenac sodium: I. application of factorial design and evaluation of release kinetics.
    Açikgöz M; Kaş HS; Orman M; Hincal AA
    J Microencapsul; 1996; 13(2):141-59. PubMed ID: 8999120
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of drug delivery following the administration of magnetic albumin microspheres containing adriamycin to the rat.
    Gallo JM; Gupta PK; Hung CT; Perrier DG
    J Pharm Sci; 1989 Mar; 78(3):190-4. PubMed ID: 2724075
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Target organ disposition and plasma pharmacokinetics of doxorubicin incorporated into albumin microspheres after intrarenal arterial administration.
    Kerr DJ; Willmott N; McKillop JH; Cummings J; Lewi HJ; McArdle CS
    Cancer; 1988 Sep; 62(5):878-83. PubMed ID: 3409170
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Adriamycin-loaded albumin microspheres: preparation, in vivo distribution and release in the rat.
    Willmott N; Cummings J; Stuart JF; Florence AT
    Biopharm Drug Dispos; 1985; 6(1):91-104. PubMed ID: 3921079
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Increased anti-tumor effect of adriamycin-loaded albumin microspheres is associated with anaerobic bioreduction of drug in tumor tissue.
    Willmott N; Cummings J
    Biochem Pharmacol; 1987 Feb; 36(4):521-6. PubMed ID: 3827939
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Physiological pharmacokinetic model of adriamycin delivered via magnetic albumin microspheres in the rat.
    Gallo JM; Hung CT; Gupta PK; Perrier DG
    J Pharmacokinet Biopharm; 1989 Jun; 17(3):305-26. PubMed ID: 2810070
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Aminophylline targeting to lung: optimization of the size and drug loading of albumin microspheres.
    Tripathi KP; Singh J
    J Microencapsul; 1992; 9(2):229-35. PubMed ID: 1593406
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of carrier dose on the multiple tissue disposition of doxorubicin hydrochloride administered via magnetic albumin microspheres in rats.
    Gupta PK; Hung CT
    J Pharm Sci; 1989 Sep; 78(9):745-8. PubMed ID: 2585268
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Application of regression analysis in the evaluation of tumor response following the administration of adriamycin either as a solution or via albumin microspheres to the rat.
    Gupta PK; Hung CT; Lam FC
    J Pharm Sci; 1990 Jul; 79(7):634-7. PubMed ID: 2398473
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ultrastructural disposition of adriamycin-associated magnetic albumin microspheres in rats.
    Gupta PK; Hung CT; Rao NS
    J Pharm Sci; 1989 Apr; 78(4):290-4. PubMed ID: 2724092
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Magnetic microspheres: synthesis of a novel parenteral drug carrier.
    Widder K; Flouret G; Senyei A
    J Pharm Sci; 1979 Jan; 68(1):79-82. PubMed ID: 569198
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.